Page 2 - Simulations Plus News Today

Simulations Plus (NASDAQ:SLP – Get Free Report) issued its quarterly earnings results on Wednesday. The technology company reported $0.20 EPS for the quarter, beating the consensus estimate of $0.18 by $0.02, Briefing.com reports. Simulations Plus had a return on equity of 8.02% and a net margin of 16.22%. The firm had revenue of $18.31 million […]

Simulations Plus (NASDAQ: ) just reported results for the second quarter of 2024. InvestorPlace Earnings is a project that leverages data from TradeSmith to…

U.S. stock futures were higher this morning, with the Dow futures gaining by around 90 points on Thursday. Shares of Simulations Plus, Inc. (NAS...

Predicting DILI risk supports informed decision-making regarding drug evaluations and approvals ...

U.S. stock futures were higher this morning, with the Dow futures gaining by around 90 points on Thursday.

Simulations Plus, Inc. beats earnings expectations. Reported EPS is $0.1983, expectations were $0.18. Simulations Plus, Inc.

-- Technology stocks were rising premarket Thursday, with the Technology Select Sector SPDR Fund gaining 0.4% while the SPDR S&P Semiconductor ETF was flat. Simulations Plus surged past 10% after...

-- Simulations Plus said Thursday that the US Food and Drug Administration has renewed its licenses to the DILIsym software platform. Financial details werent disclosed. The one-year renewal will...

Simulations Plus, Inc. announced that the U.S. FDA has renewed its licenses to the DILIsym software platform. DILIsym is the industry gold standard for quantitative systems toxicology software...

Shares of Simulations Plus, Inc. (NASDAQ:SLP – Get Free Report) gapped up before the market opened on Thursday following a better than expected earnings announcement. The stock had previously closed at $38.46, but opened at $44.91. Simulations Plus shares last traded at $46.28, with a volume of 95,888 shares changing hands. The technology company reported […]